Administration of the benzodiazepine triazolam at the appropriate time in the circadian cycle has been shown to induce phase shifts in hamster circadian rhythms. These phase shifts can be blocked by geniculo-hypothalamic tract (GHT) ablation or by restraint of activity. The present study examined the effects of the benzodiazepine chlordiazepoxide on running-wheel activity rhythms of hamsters. The phase-advancing effect of intraperitoneal injections of chlordiazepoxide administered at circadian time 6 (Cq" 6) was dose-dependent. Average shifts ranged from 6 min at a dose of 0.05 mg/kg to 135 min at a dose of 200 mg/kg. Four of twenty hamsters did not show a phase shift to any dose tested. Phase advance shifts to chlordiazepoxide (CT 6; 100 mg/kg) were blocked by GHT lesions. Chiordiazepoxide injections at doses which induced phase shifts were often followed by sedation. These results indicate that chlordiazepoxide is similar to triazolam, in that its ability to induce phase shifts at circadian time 6 is blocked by GHT lesions.
INTRODUCTION
The biological clock for circadian rhythms appears to be located in the suprachiasmatic nuclei (SCN) 17'24'25.
The SCN receive direct input from the retina via the retinohypothalamic tract (RHT) 9'2°. There is also a second indirect pathway from the retina to the SCN via the geniculo-hypothalamic tract (GHT) 17'29. The GHT originates at least in part from neuropeptide Y-immunoreactive cells in the intergeniculate leaflet and the ventral lateral geniculate nucleus 2'5.
Several benzodiazepines have been shown to induce phase shifts in circadian locomotor activity of rodents. Benzodiazepines tested include triazolam, diazepam and midazolam 8'22'31'35 . Recent studies have indicated that phase shifts induced by triazolam can be blocked by restraint of activity immediately following injection 33 and also by lesions of the GHT ~°. These results indicate that triazolam-induced phase shifts may require an increase in activity and that the GHT may mediate these phase shifts.
This study examines the effects of a longer-acting and water-soluble benzodiazepine, chlordiazepoxide. This benzodiazepine was chosen for investigation because, unlike triazolam, chlordiazepoxide can be dissolved in saline for electrophysiological studies of the SCN. We have shown that chlordiazepoxide produces a dosedependent suppression of spontaneous firing rate of SCN cells and potentiates the gamma-aminobutyric acid (GABA)-induced inhibitory responses 15, 16 . These chlordiazepoxide-induced effects appear to be mediated via GABA A receptors as they were blocked by the GABA A receptor antagonist bicuculline 15A6.
Preliminary behavioral studies in hamsters ~4 indicated that phase advance shifts were induced by chlordiazepoxide administered 6 h before lights off in hamsters housed under a light:dark cycle. This result is similar to results from studies using triazolam and midazolam 31' 32,35. In this study we generated a dose-response curve for chlordiazepoxide-induced phase shifts at circadian time (CT) 6. We also tested if lesions of the GHT block phase-shifting effects of chlordiazepoxide.
MATERIALS AND METHODS

Animals and housing
Adult male golden hamsters (Mesocricetus auratus; 90-100 g) were purchased from Charles River laboratories (Wilmington, MA). Hamsters were housed in individual cages (46 x 25 x 20 cm) equipped with a running wheel (17 cm in diameter). Food and water were available ad libitum. Running wheel activity was monitored continuously by an IBM computer using Dataquest III software (Data Sciences Inc., Roseville, MN). Actograms were produced by plotting log-transformed data for each day on a 24 h scale with 15
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Hamsters were housed under either light:dark (LD) 14:10 h (14 h light:10 h dark; lights on at 14.00 h) or under constant dim light (LL). The range of the light intensity under LL within individual cages was 0.20-0.55 gW/cm 2 (0.01-0.02 lux; from a General Electric 'Dawn Pink' 60-W bulb).
Hamsters were injected i.p. with either 0.9% saline or various doses of chloradiazepoxide (Sigma) dissolved in 0.9% saline. All injections were timed to occur at CT 6 (approximately 6 h prior to activity onset, corrected for the period of the animal's free-running rhythm). This is a phase at which maximal phase advances to other benzodiazepines have been obtained 31'35. Hamsters were randomly assigned to either the experimental or control groups.
A. The phase-shifting effects of chlordiazepoxide were assessed by visual inspection of actograms. Phase shifts were determined by using eye-fit lines to predict the onset of activity the day after the injection from the pattern of onsets 10 days prior to injection. This onset of activity was compared with the onset predicted for the same day provided from 10 days of activity after the system showed a steady state following the injection.
Dose-response curve
Upon arrival 20 hamsters were group housed under LD 14:10 h for 10 days and then individually housed under the same LD cycle for 1 week. The animals were then exposed to LL. After 3 weeks under LL, hamsters were injected with either 0.05, 0.5, 5 mg/kg chlordiazepoxide (n = 5 animals per dose) or saline (n = 5). Two weeks later, hamsters were injected with other doses of chlordiazepoxide (2 (n = 4), 20 (n = 5), 100 (n = 5), or 200 (n = 2) mg/kg) or saline (n = 4). Hamsters were assigned to the second treatment groups in a quasi-random manner. Hamsters remained under EL for another 10 days.
Some animals (n = 4) showed no shift to either of the two doses of chordiazepoxide administered. Since initial doses were less than 100 mg/kg, these animals were later injected with 100 mg/kg of chlordiazepoxide in an effort to establish if they were responsive to the phase-shifting effects of chlordiazepoxide.
Geniculo-hypothalamic tract lesions
Animals (n = 19) were housed under LD 14:10 h for 2 weeks followed by LL for 2 weeks. All animals were then injected with 100 mg/kg chlordiazepoxide at CT 6. Phase shifts were evaluated and hamsters were allowed to free-run in LL for another 2 weeks. Two animals died 10 and 15 days following the first injections of chlordiazepoxide. These deaths may have been a direct result of the injections since animals showed low activity and diminished appetite subsequent to the injection. Remaining hamsters were randomly assigned to either experimental (GHT lesion; n = 13) or control (anesthetized but unoperated; n = 4) groups. One animal died soon after surgery, leaving 12 animals in the lesion group.
Hamsters were anesthetized with sodium pentobarbital anesthesia (80 mg/kg) and positioned in a Kopf stereotaxic instrument with the incisor bar 2.0 mm below the interaural line. Lesions were produced using a Grass LM4 lesion maker. The lesion electrode was constructed from an insect pin insulated to 0.5 mm from the tip. Three lesions were placed on either side of the midline (coordinates: 1.6, 1.1 and 0.6 mm posterior to bregma, 2.9, 3.15 and 3.2 mm lateral to the midline; and 5.0, 4.6 and 4.4 mm ventral to dura). Ten mA was passed for 15 s at each lesion site. Animals received a single dose of an analgesic, buprenorphine hydrochloride (0.1 ml of solution of 0.3 mg/ml; Bruprenex, Norwich Easton) during recovery.
After 2 weeks in LL, hamsters were again injected with 100 mg/kg chlordiazepoxide at CT 6. The experiment ended 2 weeks later. Hamsters were given a lethal dose of sodium pentobarhitai. They were perfused sequentially with 0.9% saline and 10% buffered formalin. The brains were removed and stored overnight in a 30% sucrose:10% formalin solution. Frontal sections (40/tm) were cut using a freezing stage microtome. Sections through the diencephalon were stained with the Kliiver-Barrera method for cells and fibers 11. Damage to areas containing GIIT neurons was assessed by one observer (M.E.H.). These areas (the external portion of the anterior ventral lateral geniculate nucleus and the intergeniculate leaflet) were defined in prior retrograde tracing and immunohistochemical studies 5. Preliminary work indicated that this observer can assess such lesions from the Kliiver-Barrera stain as reliably as from an immunohistochemical stain.
RESULTS
Dose-response curve
Phase-shifts to chlordiazepoxide were dose dependent 
.is. 
Geniculo-hypothalamic tract lesions
Sixteen of 17 hamsters exhibited phase advances to 100 mg/kg chlordiazepoxide prior to surgery (mean + S.E.M. advance: 35 + 7 min). After surgery 4 of 12 GHT-lesion hamsters, as compared to all 4 control animals, showed a measurable phase advance (see Fig. 2 ). Postsurgery shifts were significantly different from presurgery shifts for animals in the lesion group (tll = 3.02, P < 0.02) but not the control group (t 3 = 1.26, n.s.). The average postsurgery phase advance of the control group was 69 + 38 min, compared to 5 + 3 min for the lesion group. The hamster showing no phase shift to chlordiazepoxide prior to surgery showed no phase shift to chlordiazepoxide after receiving a GHT lesion. No significant change was observed in the free-running period of hamsters after chordiazepoxide injection (mean + S.E.M. period: preinjection, 23.99 + 0.01 h; postinjection, 24.00 + 0.01 h; t-test, n.s.).
Histological analysis revealed that the locus of origin of the GHT, the intergeniculate leaflet and anterior portions of the ventral lateral geniculate nucleus 5, were extensively damaged in most hamsters. Seven hamsters showed >90% GHT ablation, 4 hamsters had >70% GHT ablation and one hamster had <10% GHT ablation. For these groups of animals the mean postsurgery phase shift was 0, 12.5 and 10 min, respectively (see Fig.  3 ). The mean difference between pre-and postsurgery shifts was 33, 30 and 0 min. Damage extended into portions of the fornix, hippocampus, reticular thalamic nuclei, dorsal lateral geniculate nucleus, medial geniculate nucleus and ventral thalamic nuclei.
DISCUSSION
These results establish that intraperitoneal injections of the benzodiazepine chiordiazepoxide can advance the circadian clock of the golden hamster in a dose-dependent manner. Doses of 0.5 mg/kg or larger, administered at CT 6, produced phase advances in the circadian locomotor activity of most hamsters. Lesions of the GHT blocked chlordiazepoxide-induced phase shifts.
The effects of chlordiazepoxide observed in this study are consistent with findings following administration of the benzodiazepines triazolam, diazepam and midazolam 8"31'35. While the absolute amplitude of phase advances produced by a CT 6 injection of chlordiazepoxide (100 mg/kg) was slightly less than that induced by triazolam or midazolam, the direction of the phase-shift is identical. The variation in amplitude of phase shifts could be attributed to differences in duration, action, and/or metabolism of the specific drugs 4. It is unclear if maximal phase advances were obtained since we were unable to test doses greater than 200 mg/kg and the two animals given this higher dose appeared to show larger phase shifts than the 5 hamsters who received 100 mg/kg. Solubility factors and the desire to maintain a consistent, yet small, injection volume across doses limited us to this maximum dose. The two hamsters receiving 200 mg/kg chlordiazepoxide appeared heavily sedated and showed low activity levels for several days following the injections. Although data is not available for hamsters, the lethal dose (LDs0) for i.p. injections of chlordiazepoxide is 276 mg/kg for rats and 200 mg/kg for mice 3°. Since several animals died after injections of 100 mg/kg, it is possible that this dose is near toxic levels for hamsters as well.
Four hamsters in the dose-response experiment did not respond to any dose of chlordiazepoxide tested and were classified as non-responders. No difference in either amplitude, duration or period of the wheel-running activity rhythm was observed between the responders and non-responders. As drug dosage increased, more disruption of activity followed the injection. However, this disruption did not appear to be related to the phaseshifting effect of chlordiazepoxide, since both responders and non-responders showed similar disruptions of activity levels.
The phase-response curve (PRC) obtained by electrical stimulation of the GHT 26 or by microinjection of neuropeptide Y into the SCN 1 is similar to that produced by triazolam injections 31. Lesions of the GHT blocked phase advances evoked by chlordiazepoxide (present study), and both phase advances and delays to triazolam 1°. These data support the idea that the GHT is part of the pathway by which benzodiazepines exert their phase-shifting effects. It is impossible, however, to state definitively that all phase shifting effects of chlordiazepoxide are blocked by lesions of the GHT as only phase advances at CT 6 were examined. It is possible that the GHT lesion slightly altered the PRC to chlordiazepoxide, causing injections at CT 6 to fall in a period when the hamster was unresponsive to the drug. This would be similar to the effect of GHT lesions on the dark pulse PRC 6. GHT lesions only slightly alter the dark pulse PRC, yet cause a total block of phase shifts to 6-h dark pulses starting at CT 5-7 (ref. 6, p. 316). Alternatively, GHT lesions might alter the dose of chlordiazepoxide necessary to effect a phase shift. The effectiveness of partial GHT ablation in altering phase shift responses was unclear. On average, hamsters with <90% GHT ablation showed larger phase shifts after surgery than did hamsters with :>90% GHT ablation; however, when the difference between an individual's pre-and postsurgery phase shifts was considered, these groups were similar (see Results). These data leave open the question of whether GHT neurons form the critical locus for the lesion effect.
Triazolam-induced phase shifts may be mediated by an increase in locomotor activity. If a hamster is restrained, triazolam injections no longer induce phase shifts 33. Restraint can also block phase shifts to dark pu|ses 33. Findings in the present study, however, indicate that chlordiazepoxide phase-shifts circadian rhythms in a manner similar to triazolam, yet animals appeared sedated for approximately 2 h immediately following chlordiazepoxide injections.
Similar to this, triazolam induces both phase shifts and sedation in squirrel monkeys 19. Some hamsters did show poorly coordinated motor activity, often including small bouts of wheel-running activity after chlordiazepoxide injections (see Fig. 2) . A study utilizing direct behavioral observation and formally comparing the amount and type of activity observed after injections of each of these drugs would be useful.
Benzodiazepines appear to exert their phase-shifting effects by binding to a site on the GABA A receptor. Microinjection of the GABA A agonist muscimol into the area of the SCN produces phase shifts similar to those induced by benzodiazepines 28. Bicuculline, a selective GABA A antagonist, has been shown to block the phase-shifting effects of benzodiazepines TM. In contrast to their direct phase-shifting effects, benzodiazepines may alter phase-shift responses to light by a more complex mechanism, perhaps involving a binding site other than the GABA A receptor. Phase-advancing effects of light are reduced by benzodiazepines and although this effect can be blocked by GABA A antagonists it is not mimicked by GABA A agonists 23. The GABA A antagonist bicuculline blocks light-induced phase delays, but picrotoxin, which directly blocks chloride channels, and FG 7142, an inverse agonist of the GABAA-BDZ receptor, do not show effects similar to bicuculline 23. Light-induced phase advances and delays can also be reduced by the GABA B agonist baclofen 23 .
While it appears that the GHT is a necessary component for the phase-shifting action of benzodiazepines, it may be unlikely that benzodiazepines exert their main effect directly on GHT neurons as receptor ligand binding studies have found very few GABA/benzodiaze-REFERENCES Benzodiazepines could exert their effect on some pathway afferent to GHT neurons. One possibility is the raphe nuclei. GABA A receptors are found in the raphe nuclei 3'7, a source of afferents to lateral geniculate neurons 13'21. However, recent work has shown that at least the serotonergic input from the raphe to the IGL does not appear to be necessary for triazolam-induced phase shifts 27. Other brain loci containing both GABA A receptors and cells afferent to the area of origin of the GHT include pretectal nuclei, the periaqueductal gray lateral and caudal to the dorsal raphe, and the vestibular nuclei3,7,13, 21
Although the SCN have been shown to have only moderate amounts of GABA/benzodiazepine receptors, it has been shown that iontophoretic injection of benzodiazepines onto SCN cells in the hypothalamic slice preparation produces a potentiation of the GABA inhibitory response. It has been further demonstrated that this response is mediated by the GABA A receptor TM 15,16. It is possible, therefore, that the benzodiazepines do exert their effects directly on the SCN but require some interaction with the GHT to effect phase shifts of behavioral rhythms. Alternatively, phase shifts might be dependent on the projection from SCN-area neurons to the lateral geniculate 34 which would also be disrupted by our lesions.
In summary, this study has shown that: (1) phase advances to the benzodiazepine chlordiazepoxide are dose dependent; (2) not all hamsters show phase shifts to chlordiazepoxide administered at CT 6; and (3) chlordiazepoxide-induced phase advances are absent after GHT-ablation.
